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MI at 1 year was obtained by the GRACE RS but the performance of the PURSUIT and
TIMI RS was good. We found a statistically significant interaction between the risk strati-
fied by the best cut-off value for the GRACE and PURSUIT RS and myocardial revascu-
larization, with a prognostic benefit for the higher risk patients.
Conclusions: The risk scores studied demonstrated a good predictive accuracy for D or
MI at 1 year and allowed the identification of high risk subsets of patients that most bene-
fit from myocardial revascularization performed during the initial hospital stay. 
1098-78 Low Hemoglobin Predicts Worse Clinical Outcomes in 
Acute Coronary Syndromes
Marc S. Sabatine, David A. Morrow, Robert P. Giugliano, Sabina A. Murphy, Carolyn H. 
McCabe, C. Michael Gibson, Christopher P. Cannon, Elliott M. Antman, Eugene 
Braunwald, for the TIMI Study Group, Brigham and Women's Hospital, Boston, MA
Background: In acute coronary syndromes (ACS), anemia has the potential to worsen
myocardial ischemia by further compromising oxygen delivery. We sought to determine
the impact of anemia on clinical outcomes in a broad cohort of patients with ACS.
Methods: Data from 22,333 patients with STEMI and 17,547 patients with UA/NSTEMI
from the pooled TIMI trial databases were analyzed. Baseline hemoglobin (Hgb) levels
were categorized in 1 g/dl increments. Multivariable logistic regression was used to
adjust for age, sex, hypertension, diabetes, smoking, renal insufficiency, prior MI, prior
CHF, prior ASA, prior CABG, and index revascularization.
Results: Lower baseline Hgb levels were associated with greater evidence of acute myo-
cardial injury in both STEMI (higher rates of Killip class II-IV and LBBB, p<0.001 for each)
and UA/NSTEMI (higher rates of ST deviation and higher peak troponin, p<0.001 for
each). In STEMI, patients with lower baseline Hgb levels had higher mortality at 30 days
(p<0.001) and in UA/NSTEMI they had higher rates of death, MI, or recurrent ischemia
(p<0.001). These associations remained significant even after adjusting for potential con-
founders and the adjusted odds ratios and 95% confidence intervals are presented in the
Figure.
Conclusion: Low Hgb on admission is independently associated with worse outcomes in
patients with ACS. These findings suggest that efforts to raise Hgb may be beneficial in
this setting. 
1098-79 Renal Function Predicts Outcomes in Acute Coronary 
Syndromes: Insights From the CURE Trial
Matyas Keltai, Marcello Tonelli, Johannes F. Mann, Basil Lewis, Steven Hawken, Shamir 
Mehta, Nasser Lakkis, Salim Yusuf, Hungarian Institute of Cardiology, Budapest, 
Hungary, McMaster University, Hamilton, ON, Canada
Background: Chronic renal insufficiency (CRI) is associated with increased mortality in
coronary artery disease. The aim of this study was to assess the relationship between
various degree of renal insufficiency and prognosis in patients (pts) with acute coronary
syndromes (ACS) Additionally we assessed if benefit of clopidogrel treatment is modified
in pts with CRI.
Methods: In the CURE trial 12.253 patients (97.5 %) had a baseline serum creatinine
measurement at enrollment. From this measurement the glomerular filtration rate (GFR)
was estimated using the MDRD equation, and the outcomes of patients with and without
CRI were compared.
Results: 3262 patients (26.2 %) had a GFR < 60 ml/min, corresponding to at least mod-
erate CRI. Patients with CRI were significantly older (70.3 +9.5, versus 62.0 +11.0).
Among patients with CRI there were more females (53.8, versus 32.8 % in the group
without CRI), and significantly more hypertensives (70, versus 54.9 %), diabetics (29,
versus 20.3 %) and more patients with previous myocardial infarction (39.8, versus 29.5
%). Major vascular events (cardiovascular death/myocardial infarction/stroke) occured
more frequently in patients with CRI (GFR>60 - 8.6 %; GFR 30.1-60 - 14.4 %;GFR 0-30
25.5 %). A significant gradient was present in all secondary outcome measures relative
to GFR. The beneficial effect of adding clopidogrel to standard treatment of ACS was
similar and statistically significant in pts below and above the median value of GFR, with
no evidence of statistical heterogeneity (RR 0.83; 95 % CI:0.72-0.95, versus 0.73; 95 %
CI: 0.61-0.87). The risk of major/life-threatening bleeding was increased in patients with
CRI in the CURE trial population (2.1 versus 1.0 %), this risk only moderately increased
by adding clopidogrel, and the hazard ratio was similar in patients with CRI (HR 1.5 +
1.16 - 1.92) and without CRI (HR 1.14+ 0.83 - 1.59).
Conclusion: CRI carries a poor prognosis in pts with non ST elevation ACS. Adding clo-
pidogrel to standard treatment of ACS was safe and resulted in a decreased incidence of
major cardiovascular outcomes in patients with and without CRI .
1098-80 High-Normal Creatinine: An Underappreciated Predictor 
of Poor Outcomes in Chest Pain Patients
Charles A. Henrikson, David E. Bush, Eric E. Howell, Nisha Chandra-Strobos, Johns 
Hopkins Medical Institutions, Baltimore, MD
Background: Patients with renal insufficiency have poor outcomes following acute myo-
cardial infarction (MI) or unstable angina. However, little investigation has focused on the
impact of high-normal creatinine on clinical outcomes.
Methods: We prospectively followed 459 patients with ongoing chest pain admitted to the
hospital with suspected myocardial ischemia. Patients with elevated creatinine (>=1.4
mg/dL, n=58) were excluded.
Results: Patients with high-normal creatinine (1.0-1.3 mg/dL, n=129), compared to those
with low-normal creatinine (<1.0 mg/dL, n=272), tended to be male (66% v. 36%), hyper-
tensive (66% v. 52%), and older (62 +/-16 v. 55 +/- 15 yrs (mean+/-SD)) (all p<0.05), but
the rates of diabetes mellitus (24% v. 20%), high cholesterol (36% v. 44%), and MI at pre-
sentation (16% v. 10%) were similar (all p=NS). Among patients with high-normal creati-
nine, 22% (unadjusted) suffered a subsequent MI, revascularization, or death by 120
days. This compares to 13% in patients with low-normal creatinine (p<0.05). The Kaplan-
Meier curve, adjusted for baseline differences between the two groups, confirmed a
higher rate of subsequent MI, revascularization, or death in the high-normal creatinine
group as compared to the low-normal creatinine group, mainly attributable to an increase
in early events (p<0.05).
Conclusion: These data identify high-normal creatinine as an independent, albeit under-
appreciated, risk factor for poor outcomes in patients with suspected myocardial
ischemia.
1098-81 Which White Blood Cell Compartments Predict 
Increased Cardiovascular Risk?
Jerry M. John, Jeffrey L. Anderson, Benjamin D. Horne, Tami L. Bair, Kurt R. Jensen, 
Heath U. Jones, Dale G. Renlund, Joseph B. Muhlestein, LDS Hospital, Salt Lake City, 
UT, University of Utah, Salt Lake City, UT
Background: Epidemiological observations have associated an elevated white blood cell
(WBC) count with the development of cardiovascular disease, but which leukocyte com-
partments carry this risk is uncertain.
Methods: Patients entered into the Intermountain Heart Collaborative Study Registry
between 1994–2001 who had angiographic assessment of coronary artery disease
(CAD), a baseline total and differential WBC count, and long-term follow-up for death or
nonfatal myocardial infarction (MI) were studied. Patients (pt) with acute MI were
excluded from primary analyses. The predictive value for D/MI of total WBC, neutrophil
(N), lymphocyte (L), monocyte (M) counts, and N/L ratio was assessed using Cox regres-
sions.
Results: 3227 pt were studied. Mean age was 64; 62% were male; 53%, hypertensive;
45%, hyperlipidemic; 17%, smokers; 20%, diabetic. Time to event (N=478, 14.8%) or last
follow-up averaged 3.5 years. WBC total and compartment counts were non-normally
distributed. In univariate analysis, an increased hazard (HR) ratio was associated with
fourth (vs. first) quartile (Q) total WBC (1.4, p<0.01), N (2.0, p<0.001), L (0.41, p<0.001),
M (1.4, p<0.01), and N/L (2.7, p<<0.001) counts. In multivariable modeling (backward
conditional stepwise regression), entering standard risk factors, presentation, and CAD
severity, WBC (HR 1.4, p=0.01) and M (HR 1.3, p<0.02) were weaker and N (HR 1.8,
p<0.001), L (HR 0.51, p<0.001), and N/L (HR 2.2, p<0.001) were stronger independent
predictors of death/MI. When WBC variables were entered together, N/L was retained as
an independent predictor (HR 2.2, CI 1.7-2.9, p<<0.001), together with age, diabetes,
presentation, CAD severity, family history, and M (model chi-square 190). Risk associa-
tions persisted in analyses restricted to CAD pt or including acute MI pt.
Conclusions: Total WBC count is confirmed to be an independent predictor of D/MI in
